110 related articles for article (PubMed ID: 9670810)
1. Do viral chemokines modulate Kaposi's sarcoma?
Dittmer D; Kedes DH
Bioessays; 1998 May; 20(5):367-70. PubMed ID: 9670810
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.
Yen-Moore A; Hudnall SD; Rady PL; Wagner RF; Moore TO; Memar O; Hughes TK; Tyring SK
Virology; 2000 Feb; 267(2):247-51. PubMed ID: 10662620
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
Cannon M; Cesarman E
Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells.
Nakano K; Isegawa Y; Zou P; Tadagaki K; Inagi R; Yamanishi K
Arch Virol; 2003 May; 148(5):871-90. PubMed ID: 12721796
[TBL] [Abstract][Full Text] [Related]
7. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
Dezube BJ; Sullivan R; Koon HB
J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of viral macrophage inflammatory protein I encoded by Kaposi's sarcoma-associated herpesvirus at 1.7A.
Luz JG; Yu M; Su Y; Wu Z; Zhou Z; Sun R; Wilson IA
J Mol Biol; 2005 Oct; 352(5):1019-28. PubMed ID: 16140327
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
10. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein.
LiWang AC; Cao JJ; Zheng H; Lu Z; Peiper SC; LiWang PJ
Biochemistry; 1999 Jan; 38(1):442-53. PubMed ID: 9890927
[TBL] [Abstract][Full Text] [Related]
11. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 strains from Russian patients with classic, posttransplant, and AIDS-associated Kaposi's sarcoma.
Kadyrova E; Lacoste V; Duprez R; Pozharissky K; Molochkov V; Huerre M; Gurtsevitch V; Gessain A
J Med Virol; 2003 Dec; 71(4):548-56. PubMed ID: 14556268
[TBL] [Abstract][Full Text] [Related]
14. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
15. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
16. Molecular virology of Kaposi's sarcoma-associated herpesvirus.
Moore PS; Chang Y
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):499-516. PubMed ID: 11313008
[TBL] [Abstract][Full Text] [Related]
17. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
19. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.
Endres MJ; Garlisi CG; Xiao H; Shan L; Hedrick JA
J Exp Med; 1999 Jun; 189(12):1993-8. PubMed ID: 10377196
[TBL] [Abstract][Full Text] [Related]
20. The role of HHV-8 in Kaposi's sarcoma.
Neipel F; Fleckenstein B
Semin Cancer Biol; 1999 Jun; 9(3):151-64. PubMed ID: 10343067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
